Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 204

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Relevance of dietary glycerophospholipids and sphingolipids to human health

Castro-Gómez, P., Garcia-Serrano, A., Visioli, F., Fontecha, J. · 2015 · Prostaglandins, Leukotrienes and Essential Fatty Acids

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.plefa.2015.07.004

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 175

  1. Guo, 2005, Enzymatic modification of phospholipids for functional applications and human nutrition, Biotechnol. Adv., 23, 203, 10.1016/j.biotechadv.2005.02.001 · DOI · Paper page
  2. Pettus, 2004, Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2, J. Biol. Chem., 279, 11320, 10.1074/jbc.M309262200 · DOI · Paper page
  3. Vance, 2008, Chapter 8-phospholipid biosynthesis in eukaryotes
  4. Schlegel, 2001, Phosphatidylserine, a death knell, Cell Death Differ., 8, 551, 10.1038/sj.cdd.4400817 · DOI · Paper page
  5. Leventis, 2010, The distribution and function of phosphatidylserine in cellular membranes, Annu. Rev. Biophys, 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
  6. Mozzi, 2003, Metabolism and functions of phosphatidylserine in mammalian brain, Neurochem. Res., 28, 195, 10.1023/A:1022412831330 · DOI
  7. Gardocki, 2005, Phosphatidylinositol biosynthesis: biochemistry and regulation, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1735, 89, 10.1016/j.bbalip.2005.05.006 · DOI
  8. D’Souza, 2014, Enrichment of phosphatidylinositols with specific acyl chains, Biochim. Biophys. Acta Biomembr, 1838, 1501, 10.1016/j.bbamem.2013.10.003 · DOI
  9. Yamashita, 2013, The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55, Prostaglandins Other Lipid Mediat., 107, 103, 10.1016/j.prostaglandins.2013.05.004 · DOI
  10. Frasch, 2012, Emerging roles for lysophosphatidylserine in resolution of inflammation, Prog. Lipid Res, 51, 199, 10.1016/j.plipres.2012.03.001 · DOI
  11. Sevastou, 2013, Lysoglycerophospholipids in chronic inflammatory disorders: the PLA2/LPC and ATX/LPA axes, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1831, 42, 10.1016/j.bbalip.2012.07.019 · DOI · Paper page
  12. Arouri, 2013, Membrane-perturbing effect of fatty acids and lysolipids, Prog. Lipid Res., 52, 130, 10.1016/j.plipres.2012.09.002 · DOI
  13. Bure, 2014, Characterization of glycosyl inositol phosphoryl ceramides from plants and fungi by mass spectrometry, Anal. Bioanal. Chem., 406, 995, 10.1007/s00216-013-7130-8 · DOI
  14. Merrill, 2011, Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics, Chem. Rev., 111, 6387, 10.1021/cr2002917 · DOI · Paper page
  15. Aureli, 2011, Remodeling of sphingolipids by plasma membrane associated enzymes, Neurochem. Res., 36, 1636, 10.1007/s11064-010-0360-7 · DOI
  16. Farooqui, 2001, Book review: plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia, Neuroscientist, 7, 232, 10.1177/107385840100700308 · DOI · Paper page
  17. Lessig, 2009, Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis, Curr. Med. Chem., 16, 2021, 10.2174/092986709788682164 · DOI · Paper page
  18. Wallner, 2011, Plasmalogens the neglected regulatory and scavenging lipid species, Chem. Phys. Lipids, 164, 573, 10.1016/j.chemphyslip.2011.06.008 · DOI · Paper page
  19. Cohn, 2010, Dietary phospholipids and intestinal cholesterol absorption, Nutrients, 2, 116, 10.3390/nu2020116 · DOI · Paper page
  20. Weihrauch, 1983, Phospholipid content of foods, J. Am. Oil Chem. Soc, 60, 1971, 10.1007/BF02669968 · DOI
  21. Wang, 1997, Phospholipid fatty acid composition and stereospecific distribution of soybeans with a wide range of fatty acid composition, J. Am. Oil Chem. Soc, 74, 1587, 10.1007/s11746-997-0082-4 · doi:10.1007/s11746-997-0082-4
  22. Kullenberg, 2012, Health effects of dietary phospholipids, Lipids Health Dis., 11, 3, 10.1186/1476-511X-11-3 · DOI · Paper page
  23. Castro-Gómez, 2015, Comprehensive study of the lipid classes of krill oil by fractionation and identification of triacylglycerols, diacylglycerols, and phospholipid molecular species by using UPLC/QToF-MS, food anal, Methods
  24. Ulven, 2011, Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers, Lipids, 46, 37, 10.1007/s11745-010-3490-4 · DOI · Paper page
  25. Fong, 2007, Protein and lipid composition of bovine milk-fat-globule membrane, Int. Dairy J., 17, 275, 10.1016/j.idairyj.2006.05.004 · DOI · Paper page
  26. Rodríguez-Alcalá, 2010, Major lipid classes separation of buttermilk, and cows, goats and ewes milk by high performance liquid chromatography with an evaporative light scattering detector focused on the phospholipid fraction, J. Chromatogr. A., 1217, 3063, 10.1016/j.chroma.2010.02.073 · DOI
  27. Nilsson, 2006, Absorption and lipoprotein transport of sphingomyelin, J. Lipid Res., 47, 154, 10.1194/jlr.M500357-JLR200 · DOI · Paper page
  28. Agren, 2006, Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency, Clin. Chim. Acta; Int. J. Clin. Chem., 366, 309, 10.1016/j.cca.2005.11.006 · DOI
  29. Zierenberg, 1982, Intestinal absorption of polyenephosphatidylcholine in man, J. Lipid Res., 23, 1136, 10.1016/S0022-2275(20)38050-0 · DOI
  30. Tall, 1983, Incorporation of radioactive phospholipid into subclasses of high-density lipoproteins, Am. J. Physiol., 244, E513
  31. Richmond, 2001, Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A2-deficient mice, Gastroenterology, 120, 1193, 10.1053/gast.2001.23254 · DOI
  32. Lamaziere, 2013, Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids, Prostaglandins Leukot. Essent. Fatty Acids, 88, 149, 10.1016/j.plefa.2012.12.001 · DOI
  33. Lamaziere, 2011, Differential distribution of DHA-phospholipids in rat brain after feeding: a lipidomic approach, Prostaglandins Leukot. Essent. Fatty Acids, 84, 7, 10.1016/j.plefa.2010.11.001 · DOI
  34. Taylor, 2010, Marine phospholipids—a promising new dietary approach to tumor-associated weight loss, Support Care Cancer, 18, 159, 10.1007/s00520-009-0640-4 · DOI
  35. Duan, 2009, Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development, Prog. Lipid Res., 48, 62, 10.1016/j.plipres.2008.04.003 · DOI · Paper page
  36. Iqbal, 2009, Intestinal lipid absorption, Am. J. Physiol. Endocrinol. Metab., 296, E1183, 10.1152/ajpendo.90899.2008 · DOI · Paper page
  37. Danthine, 2000, Progress in milk fat globule membrane research: a review, Évolution des connaissances sur la membrane du globule gras du lait: Synthèse bibliographique, 80, 209
  38. Mather, 1998, Origin and secretion of milk lipids, J. Mammary Gland. Biol. Neoplasia, 3, 259, 10.1023/A:1018711410270 · DOI · Paper page
  39. Evers, 2008, Heterogeneity of milk fat globule membrane structure and composition as observed using fluorescence microscopy techniques, Int. Dairy J., 18, 1081, 10.1016/j.idairyj.2008.06.001 · doi:10.1016/j.idairyj.2008.06.001
  40. Singh, 2006, The milk fat globule membrane—a biophysical system for food applications, Curr. Opin. Colloid Interface Sci., 11, 154, 10.1016/j.cocis.2005.11.002 · DOI · Paper page
  41. Lopez, 2011, Lipid rafts in the bovine milk fat globule membrane revealed by the lateral segregation of phospholipids and heterogeneous distribution of glycoproteins, Food Chem, 120, 22, 10.1016/j.foodchem.2009.09.065 · DOI · Paper page
  42. Contarini, 2013, Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies, Int. J. Mol. Sci., 14, 2808, 10.3390/ijms14022808 · DOI · Paper page
  43. Conway, 2014, Buttermilk: much more than a source of milk phospholipids, Anim. Front., 4, 44, 10.2527/af.2014-0014 · doi:10.2527/af.2014-0014
  44. Dewettinck, 2008, Nutritional and technological aspects of milk fat globule membrane material, Int. Dairy J., 18, 436, 10.1016/j.idairyj.2007.10.014 · DOI · Paper page
  45. El-Loly, 2011, Composition, properties and nutritional aspects of milk fat globule membrane—a review, Pol. J. Food Nutr. Sci, 61, 7, 10.2478/v10222-011-0001-0 · DOI
  46. Vanderghem, 2010, Milk fat globule membrane and buttermilks: from composition to valorization, La membrane du globule gras du lait et les babeurres: De leur composition à leur valorisation, 14, 485
  47. Kuchta, 2012, Milk fat globule membrane—a source of polar lipids for colon health? A Review, Int. J. Dairy Technol., 65, 315, 10.1111/j.1471-0307.2011.00759.x · DOI
  48. Modrak, 2006, Sphingolipid targets in cancer therapy, Mol. Cancer Ther., 5, 200, 10.1158/1535-7163.MCT-05-0420 · doi:10.1158/1535-7163.mct-05-0420
  49. Dial, 2006, Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro, Cancer Chemother. Pharmacol., 57, 295, 10.1007/s00280-005-0048-x · doi:10.1007/s00280-005-0048-x
  50. Fukunaga, 2008, Marine phosphatidylcholine suppresses 1,2-dimethylhydrazine-induced colon carcinogenesis in rats by inducing apoptosis, Nutr. Res., 28, 635, 10.1016/j.nutres.2008.05.005 · DOI
  51. Hossain, 2009, Growth inhibition and induction of apoptosis of colon cancer cell lines by applying marine phospholipid, Nutr. Cancer, 61, 123, 10.1080/01635580802395725 · DOI
  52. Wijendran, 2002, Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates, Pediatr. Res., 51, 265, 10.1203/00006450-200203000-00002 · DOI · Paper page
  53. Di Marzo, 2010, Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats, Int. Dairy J., 20, 231, 10.1016/j.idairyj.2009.11.015 · DOI
  54. Snow, 2010, Dietary milk fat globule membrane reduces the incidence of aberrant crypt foci in Fischer-344 rats, J. Agric. Food Chem., 58, 2157, 10.1021/jf903617q · DOI
  55. Visioli, 2014, Milk dairy products, and their functional effects in humans: a narrative review of recent evidence, Adv. Nutr.: Int. Rev. J, 5, 131, 10.3945/an.113.005025 · DOI · Paper page
  56. Zanabria, 2014, The antiproliferative properties of the milk fat globule membrane are affected by extensive heating, Dairy Sci. Technol., 94, 439, 10.1007/s13594-014-0171-8 · doi:10.1007/s13594-014-0171-8
  57. Zhang, 2008, Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice, Anticancer Res., 28, 3631
  58. Dillehay, 1994, Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice, J Nutr., 124, 615, 10.1093/jn/124.5.615 · doi:10.1093/jn/124.5.615
  59. Schmelz, 1996, Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1, 2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis, Cancer Res., 56, 4936
  60. Lemonnier, 2003, Sphingomyelin in the suppression of colon tumors: prevention versus intervention, Arch. Biochem. Biophys., 419, 129, 10.1016/j.abb.2003.08.023 · doi:10.1016/j.abb.2003.08.023
  61. Berra, 2002, Dietary sphingolipids in colorectal cancer prevention, Eur. J. Cancer Prev., 11, 193, 10.1097/00008469-200204000-00013 · DOI
  62. Schmelz, 2004, Sphingolipids in the chemoprevention of colon cancer, Front. Biosci: J and Virtual Libr, 9, 2632, 10.2741/1422 · doi:10.2741/1422
  63. Zhang, 2008, Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice, Anticancer Res., 28, 3631
  64. Patwardhan, 2015, Sphingolipids and mitochondrial apoptosis, J Bioenerg. Biomembr., 1
  65. Li, 2006, Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents, Am. J. Pathol., 168, 1107, 10.2353/ajpath.2006.050959 · DOI · Paper page
  66. Abd El Baky, 2014, Phospholipids of some marine macroalgae: identification, antivirus, anticancer and antimicrobial bioactivities, Pharma. Chem, 6, 370
  67. Doria, 2013, Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines, J. Cell. Physiol., 228, 457, 10.1002/jcp.24152 · DOI
  68. Patel, 2014, A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer, PLoS One, 9, e88841, 10.1371/journal.pone.0088841 · DOI
  69. Sakakima, 2007, Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: in vitro and in vivo experiments, J. Hepatol., 47, 83, 10.1016/j.jhep.2007.01.030 · doi:10.1016/j.jhep.2007.01.030
  70. Sakakima, 2009, Phosphatidylcholine induces growth inhibition of hepatic cancer by apoptosis via death ligands, Hepato-Gastroenterology, 56, 481
  71. Modrak, 2004, Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer, Cancer Res., 64, 8405, 10.1158/0008-5472.CAN-04-2988 · DOI
  72. Modrak, 2000, Sphingomyelin potentiates chemotherapy of human cancer xenografts, Biochem. Biophys. Res. Commun., 268, 603, 10.1006/bbrc.2000.2178 · doi:10.1006/bbrc.2000.2178
  73. Modrak, 2002, Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts, Int. J. Oncol., 20, 379
  74. van Vlerken, 2007, Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer, Cancer Res., 67, 4843, 10.1158/0008-5472.CAN-06-1648 · DOI · Paper page
  75. Jansen, 2004, Phospholipids reduce gastric cancer cell adhesion to extracellular matrix in vitro, BMC Gastroenterol, 4, 33, 10.1186/1471-230X-4-33 · doi:10.1186/1471-230x-4-33
  76. Jantscheff, 2011, Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo, Mol. Cancer Ther., 10, 186, 10.1158/1535-7163.MCT-10-0474 · DOI
  77. Murray, 2014, Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, 1005, 10.1016/S0140-6736(14)60844-8 · DOI · Paper page
  78. Jicha, 2010, Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease, Clin. Interv. Aging, 5, 45, 10.2147/CIA.S5231 · DOI
  79. Konagai, 2013, Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: a randomized controlled trial in healthy elderly volunteers, Clin. Interventions Aging, 8, 1247, 10.2147/CIA.S50349 · DOI
  80. Lagarde, 2001, Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain, J. Mol. Neurosci.: MN, 16, 201, 10.1385/JMN:16:2-3:201 · DOI · Paper page
  81. Nagata, 2011, DL- and PO-phosphatidylcholines as a promising learning and memory enhancer, Lipids Health Dis., 10, 25, 10.1186/1476-511X-10-25 · DOI
  82. Ladd, 1993, Effect of phosphatidylcholine on explicit memory, Clin. Neuropharmacol., 16, 540, 10.1097/00002826-199312000-00007 · DOI
  83. Zeisel, 2004, Nutritional importance of choline for brain development, J. Am. Coll. Nutr., 23, 621S, 10.1080/07315724.2004.10719433 · DOI · Paper page
  84. Meck, 1999, Choline supplementation during prenatal development reduces proactive interference in spatial memory, Dev. Brain Res., 118, 51, 10.1016/S0165-3806(99)00105-4 · DOI · Paper page
  85. Tweedy, 1982, Lecithin treatment of cognitively impaired Parkinson’s patients, Eur. J. Clin. Invest., 12, 87, 10.1111/j.1365-2362.1982.tb00943.x · DOI
  86. Jayaraman, 2008, Impact of Essentiale L on ethanol-induced changes in rat brain and erythrocytes, Singapore Med. J., 49, 320
  87. Giordano, 2014, Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions, Prostaglandins Leukot. Essent. Fatty Acids, 90, 1, 10.1016/j.plefa.2013.11.002 · DOI
  88. Pepeu, 1996, A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain?, Pharmacol. Res., 33, 73, 10.1006/phrs.1996.0013 · DOI
  89. Mi, 2013, Nutritional approaches in the risk reduction and management of Alzheimer’s disease, Nutrition, 10.1016/j.nut.2013.01.024 · DOI
  90. Ritchie, 2014, Souvenaid(R): a new approach to management of early Alzheimer’s disease, J. Nutr. Health Aging, 18, 291, 10.1007/s12603-013-0411-2 · DOI
  91. Crook, 1991, Effects of phosphatidylserine in age‐associated memory impairment, Neurol, 41, 644, 10.1212/WNL.41.5.644 · DOI · Paper page
  92. Benton, 2001, The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor, Nutr. Neurosci., 4, 169, 10.1080/1028415X.2001.11747360 · DOI
  93. Hellhammer, 2010, Effects of milk phospholipid on memory and psychological stress response, Br. Food J., 112, 1124, 10.1108/00070701011080258 · DOI
  94. McDaniel, 2003, Brain-specific nutrients: a memory cure?, Nutrition, 19, 957, 10.1016/S0899-9007(03)00024-8 · DOI · Paper page
  95. Smith, 2006, Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A, Aging Cell, 5, 391, 10.1111/j.1474-9726.2006.00232.x · DOI
  96. Uauy, 2006, Nutrition in brain development and aging: role of essential fatty acids, Nutr. Rev., 64, 10.1301/nr.2006.may.S24-S33 · DOI · Paper page
  97. Crichton, 2012, Dairy consumption and cardiometabolic health: outcomes of a 12-month crossover trial, Nutr. Metab. (Lond), 9, 1, 10.1186/1743-7075-9-19 · DOI
  98. Park, 2013, The association between dairy product consumption and cognitive function in the National Health and Nutrition Examination Survey, Br. J. Nutr., 109, 1135, 10.1017/S0007114512002905 · DOI
  99. Timby, 2014, Neurodevelopment, nutrition, and growth until 12 mo of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial, Am. J. Clin. Nutr., 10.3945/ajcn.113.064295 · DOI · Paper page
  100. Tanaka, 2013, The pilot study: sphingomyelin-fortified milk has a positive association with the neurobehavioural development of very low birth weight infants during infancy, randomized control trial, Brain Dev, 35, 45, 10.1016/j.braindev.2012.03.004 · DOI · Paper page
  101. Lieber, 1990, Attenuation of alcohol‐induced hepatic fibrosis by polyunsaturated lecithin, Hepatology, 12, 1390, 10.1002/hep.1840120621 · DOI
  102. Navder, 1997, Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats, J. Nutr., 127, 1800, 10.1093/jn/127.9.1800 · DOI
  103. Gundermann, 2011, Activity of essential phospholipids (EPL) from soybean in liver diseases, Pharmacol. Rep.: PR, 63, 643, 10.1016/S1734-1140(11)70576-X · doi:10.1016/s1734-1140(11)70576-x
  104. Mak, 2003, Dilinoleoylphosphatidylcholine reproduces the antiapoptotic actions of polyenylphosphatidylcholine against ethanol-induced hepatocyte apoptosis, Alcohol.: Clin. Exp. Res, 27, 997, 10.1111/j.1530-0277.2003.tb04426.x · doi:10.1111/j.1530-0277.2003.tb04426.x
  105. Xu, 2005, DLPC attenuates alcohol-induced cytotoxicity in HepG2 cells expressing CYP2E1, Alcohol Alcohol. (Oxford, U.K.), 40, 172, 10.1093/alcalc/agh142 · DOI
  106. Cohn, 2008, Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease, Curr. Opin. Lipidol., 19, 257, 10.1097/MOL.0b013e3282ffaf96 · doi:10.1097/mol.0b013e3282ffaf96
  107. Buang, 2005, Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid, Nutrition, 21, 867, 10.1016/j.nut.2004.11.019 · DOI
  108. Demirbilek, 2006, Polyenylphosphatidylcholine pretreatment protects rat liver from ischemia/reperfusion injury, Hepatol. Res, 34, 84, 10.1016/j.hepres.2005.09.040 · DOI
  109. Singal, 2011, Antioxidants as therapeutic agents for liver disease, Liver Int., 31, 1432, 10.1111/j.1478-3231.2011.02604.x · DOI · Paper page
  110. Lieber CS, 2005, Polyenylphosphatidylcholine (PPC) is beneficial for the treatment of hepatitis C, Hepatology, 42, 695A
  111. Niederau, 1998, Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial, Leich Study Group, Hepato-gastroenterol, 45, 797
  112. Wat, 2009, Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet, Atherosclerosis, 205, 144, 10.1016/j.atherosclerosis.2008.12.004 · DOI
  113. Oosthuizen, 1998, Lecithin has no effect on serum lipoprotein, plasma fibrinogen and macro molecular protein complex levels in hyperlipidaemic men in a double-blind controlled study, Eur. J. Clin. Nutr., 52, 419, 10.1038/sj.ejcn.1600580 · DOI
  114. Wat, 2009, Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet, Atherosclerosis, 205, 144, 10.1016/j.atherosclerosis.2008.12.004 · DOI
  115. Wójcicki, 1995, Clinical evaluation of lecithin as a lipid-lowering agent, Phytother. Res, 9, 597, 10.1002/ptr.2650090814 · doi:10.1002/ptr.2650090814
  116. Kirsten, 1994, Polyenylphosphatidylcholine improves the lipoprotein profile in diabetic patients, Int. J. Clin. Pharmacol. Ther., 32, 53
  117. Ristić Medić, 2006, Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia, Nutr. Metab. Cardiovasc. Dis., 16, 395, 10.1016/j.numecd.2005.06.008 · DOI
  118. Hori, 2001, Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels in hypercholesterolemic adult male volunteers, Biosci. Biotechnol. Biochem., 65, 72, 10.1271/bbb.65.72 · DOI
  119. Eshigina, 2007, Influence of dietary therapy containing sunflower oil fortified with phospholipids on the lipid metabolism in patients with hypertension and obesity, Voprosy pitaniia, 76, 58
  120. Oosting, 2012, Size and phospholipid coating of lipid droplets in the diet of young mice modify body fat accumulation in adulthood, Pediatr. Res., 72, 362, 10.1038/pr.2012.101 · DOI
  121. Conway, 2013, Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women, Nutr., Metab. Cardiovasc. Dis., 23, 1255, 10.1016/j.numecd.2013.03.003 · DOI
  122. Conway, 2014, Effect of buttermilk consumption on blood pressure in moderately hypercholesterolemic men and women, Nutrition, 30, 116, 10.1016/j.nut.2013.07.021 · DOI
  123. Jiang, 2001, Egg phosphatidylcholine decreases the lymphatic absorption of cholesterol in rats, J. Nutric, 131, 2358, 10.1093/jn/131.9.2358 · DOI
  124. Noh, 2004, Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats, J. Nutric, 134, 2611, 10.1093/jn/134.10.2611 · doi:10.1093/jn/134.10.2611
  125. Ohlsson, 2009, Long term effects on human plasma lipoproteins of a formulation enriched in butter milk polar lipid, Lipids Health Dis., 8, 44, 10.1186/1476-511X-8-44 · doi:10.1186/1476-511x-8-44
  126. Berge, 2014, Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels, Nutr. Res., 34, 126, 10.1016/j.nutres.2013.12.003 · DOI
  127. Bunea, 2004, Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia, Altern. Med. Rev.: J. Clin. Ther, 9, 420
  128. Erős, 2009, Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis, Arthritis Res. Ther., 11, R43, 10.1186/ar2651 · DOI
  129. Hartmann, 2009, Anti-inflammatory effects of phosphatidylcholine in neutrophil leukocyte-dependent acute arthritis in rats, Eur. J. Pharmacol.., 622, 58, 10.1016/j.ejphar.2009.09.012 · DOI
  130. Treede, 2007, Anti-inflammatory effects of phosphatidylcholine, J. Biol. Chem., 282, 27155, 10.1074/jbc.M704408200 · DOI · Paper page
  131. Stremmel, 2010, Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis?, Dig. Dis. (Basel, Switzerland), 28, 490, 10.1159/000320407 · DOI
  132. Ehehalt, 2010, Phosphatidylcholine as a constituent in the colonic mucosal barrier—physiological and clinical relevance, Biochim. Biophys. Acta, 1801, 983, 10.1016/j.bbalip.2010.05.014 · DOI
  133. Karner, 2014, First multicenter study of modified release phosphatidylcholine LT-02in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses, Am. J. Gastroenterol., 109, 1041, 10.1038/ajg.2014.104 · DOI
  134. Schneider, 2010, Lipid based therapy for ulcerative colitis—modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation, Int. J. Mol. Sci., 11, 4149, 10.3390/ijms11104149 · DOI
  135. Lichtenberger, 2009, Gastrointestinal safety and therapeutic efficacy of parenterally administered phosphatidylcholine-associated indomethacin in rodent model systems, Br. J. Pharmacol., 157, 252, 10.1111/j.1476-5381.2009.00159.x · doi:10.1111/j.1476-5381.2009.00159.x
  136. Leyck, 1985, Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon 100), Eur. J. Pharmacol., 117, 35, 10.1016/0014-2999(85)90469-8 · doi:10.1016/0014-2999(85)90469-8
  137. Vigerust, 2013, Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α, Eur. J. Nutr., 52, 1315, 10.1007/s00394-012-0441-2 · DOI
  138. Tou, 2007, Krill for human consumption: nutritional value and potential health benefits, Nutr. Rev., 65, 63, 10.1111/j.1753-4887.2007.tb00283.x · DOI · Paper page
  139. Deutsch, 2007, Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms, J. Am. Coll. Nutr., 26, 39, 10.1080/07315724.2007.10719584 · DOI · Paper page
  140. Ierna, 2010, Supplementation of diet with krill oil protects against experimental rheumatoid arthritis, BMC Musculoskelet Disord, 11, 1, 10.1186/1471-2474-11-136 · DOI
  141. Sampalis, 2003, Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea, Altern. Med. Rev: J. Clin. Ther., 8, 171
  142. Innis, 2007, Dietary (n-3) fatty acids and brain development, J. Nutr., 137, 855, 10.1093/jn/137.4.855 · DOI · Paper page
  143. Cowart, 2009, Sphingolipids: players in the pathology of metabolic disease, rends, Endocrinol. Metab, 20, 34
  144. Duan, 2005, Anticancer compounds and sphingolipid metabolism in the colon, In vivo (Athens, Greece), 19, 293
  145. Maines, 2010, Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn’s disease, Inflammopharmacology, 18, 73, 10.1007/s10787-010-0032-x · DOI
  146. Maines, 2008, Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase, Dig. Dis. Sci., 53, 997, 10.1007/s10620-007-0133-6 · DOI · Paper page
  147. Chatterton, 2013, Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns, Int. J. Biochem. Cell Biol., 45, 1730, 10.1016/j.biocel.2013.04.028 · DOI · Paper page
  148. Maczek, 1998, Environmental influence on age-related changes of human lymphocyte membrane viscosity using severe combined immunodeficiency mice as an in vivo model, Exp. Gerontol., 33, 485, 10.1016/S0531-5565(98)00011-4 · DOI
  149. Miranda, 2008, Soy lecithin supplementation alters macrophage phagocytosis and lymphocyte response to concanavalin A: a study in alloxan-induced diabetic rats, Cell Biochem. Funct., 26, 859, 10.1002/cbf.1517 · doi:10.1002/cbf.1517
  150. Jannace, 1992, Effects of oral soy phosphatidylcholine on phagocytosis, arachidonate concentrations, and killing by human polymorphonuclear leukocytes, Am. J. Clin. Nutr., 56, 599, 10.1093/ajcn/56.3.599 · DOI
  151. Robertson, 2014, Genotoxicity test and subchronic toxicity study with Superba™ krill oil in rats, Toxicol. Rep, 1, 764, 10.1016/j.toxrep.2014.07.007 · DOI
  152. Veereman-Wauters, 2012, Milk fat globule membrane (INPULSE) enriched formula milk decreases febrile episodes and may improve behavioral regulation in young children, Nutrition, 28, 749, 10.1016/j.nut.2011.10.011 · doi:10.1016/j.nut.2011.10.011
  153. Mandala, 2002, Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists, Science (New York, N.Y.), 296, 346, 10.1126/science.1070238 · DOI · Paper page
  154. El Alwani, 2006, Bioactive sphingolipids in the modulation of the inflammatory response, Pharmacol. Ther., 112, 171, 10.1016/j.pharmthera.2006.04.004 · DOI · Paper page
  155. Wang, 1994, Phospholipids prevent enteric bacterial translocation in the early stage of experimental acute liver failure in the rat, Scand. J. Gastroenterol., 29, 1117, 10.3109/00365529409094897 · DOI
  156. Sinibaldi, 1992, Role of phospholipids in BK virus infection and haemagglutination, Microbiology, 15, 337
  157. Chirkov, 2002, The antiviral activity of chitosan (review), Appl. Biochem. Microbiol, 38, 1, 10.1023/A:1013206517442 · DOI · Paper page
  158. Sprong, 1998, Phospholipid-rich butter milk decreases the gastro-intestinal survival and translocation of listeria in rats, Gastroenterology, 114, A1090, 10.1016/S0016-5085(98)84431-4 · doi:10.1016/s0016-5085(98)84431-4
  159. Sprong, 2001, Bactericidal activities of milk lipids, Antimicrob. Agents Chemother., 45, 1298, 10.1128/AAC.45.4.1298-1301.2001 · DOI · Paper page
  160. Haug, 2007, Bovine milk in human nutrition—a review, Lipids Health Dis., 6, 1, 10.1186/1476-511X-6-25 · DOI · Paper page
  161. Kingsley, 2006, Effects of phosphatidylserine on exercise capacity during cycling in active males, Med. Sci. Sports Exer., 38, 64, 10.1249/01.mss.0000183195.10867.d0 · DOI
  162. Monteleone, 1990, Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans, Neuroendocrinology, 52, 243, 10.1159/000125593 · DOI
  163. Jäger, 2007, Phospholipids and sports performance, J. Int. Soc. Sports Nutr, 4, 10.1186/1550-2783-4-5 · DOI
  164. Starks, 2008, The effects of phosphatidylserine on endocrine response to moderate intensity exercise, J. Int. Soc. Sports Nutr, 5, 10.1186/1550-2783-5-11 · DOI
  165. Fagan, 2004, Liquid chromatographic analysis of milk phospholipids with on-line pre-concentration, J. Chromatogr. A., 1054, 241, 10.1016/j.chroma.2004.04.051 · DOI
  166. Avalli, 2005, Determination of phospholipids in dairy products by SPE/HPLC/ELSD, J. Chromatogr. A., 1071, 185, 10.1016/j.chroma.2005.01.072 · doi:10.1016/j.chroma.2005.01.072
  167. Rombaut, 2006, Phospho- and sphingolipid distribution during processing of milk, butter and whey, J. Food. Technol., 41, 435, 10.1111/j.1365-2621.2005.01091.x · doi:10.1111/j.1365-2621.2005.01091.x
  168. Rombaut, 2007, Phospho- and sphingolipid content of selected dairy products as determined by HPLC coupled to an evaporative light scattering detector (HPLC-ELSD), J. Food Compos. Anal., 20, 308, 10.1016/j.jfca.2006.01.010 · doi:10.1016/j.jfca.2006.01.010
  169. Fauquant, 2007, Membrane phospholipids and sterols in microfiltered milk fat globules, Eur. J. Lipid Sci. Technol., 109, 1167, 10.1002/ejlt.200700119 · DOI
  170. Lopez, 2008, Phospholipid, sphingolipid, and fatty acid compositions of the milk fat globule membrane are modified by diet, J. Agric. Food. Chem., 56, 5226, 10.1021/jf7036104 · doi:10.1021/jf7036104
  171. Sánchez-Juanes, 2009, Glycosphingolipids from bovine milk and milk fat globule membranes: a comparative study. Adhesion to enterotoxigenic Escherichia coli strains, Biol. Chem., 390, 31, 10.1515/BC.2009.003 · doi:10.1515/bc.2009.003
  172. Gallier, 2010, Composition and fatty acid distribution of bovine milk phospholipids from processed milk products, J. Agric. Food Chem., 58, 10503, 10.1021/jf101878d · DOI
  173. Le, 2011, Improved solvent extraction procedure and high-performance liquid chromatography-evaporative light-scattering detector method for analysis of polar lipids from dairy materials, J. Agric. Food Chem., 59, 10407, 10.1021/jf200202d · DOI
  174. Garcia, 2012, Phospholipid fingerprints of milk from different mammalians determined by 31P NMR: towards specific interest in human health, Food Chem., 135, 1777, 10.1016/j.foodchem.2012.05.111 · DOI · Paper page
  175. Castro-Gomez, 2014, Total milk fat extraction and quantification of polar and neutral lipids of cow, goat, and ewe milk by using pressurized liquid system and chromatographic techniques, J. Dairy Sci, 97, 6719, 10.3168/jds.2014-8128 · DOI

Cited by

See all 204

Metadata

Authors
Castro-Gómez, P., Garcia-Serrano, A., Visioli, F., & Fontecha, J.
Venue
Prostaglandins, Leukotrienes and Essential Fatty Acids
Publisher
Elsevier BV
Published
2015-10
Volume
101
Pages
41-51
ISSN
0952-3278 (ISSN-L)
OpenAlex
W1833241093
Cited by
204
References
3
FWCI
8.67
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Spanish Ministry of Science and Innovation and European FEDER (AGL 2011-26713, AGL 2015-56464, ALIBIRD-CM S2013/ABU-2728)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.